+44 (0)1865-842-976 (UK)

+91 20 30108 270 (ASIA)

After spending lots of time and efforts on clinical testing, these unique “living medicines” are finally poised to hop from the realm of clinical research to the world of mainstream medicine. To give these therapies their best chance of success, the cell and gene therapy industry needs to ensure that each step of the drug development and delivery process is as robust and cost-effective as possible.

The main challenges still lie in the manufacturing and delivery processes which needs to be closely examined for optimization opportunities to further maximize the chances for effectiveness in patients.

At the 3rd Annual Bioprocessing of Advanced Cellular Therapies Congress, scheduled from 29th - 30th May, 2018 , we aim to address these exact challenges from the manufacturing processes of cell and gene therapy to safety, quality, logistics and regulatory hurdles. We will also be discussing the implementation of automated, highly validated protocols and tools which can give these therapies the best chance of success.

conference Registration Form



Academic Delegate€399
Industry Delegate €499
Solution Provider Delegate€999


Key Sessions

  • Regulatory and Reimbursement
  • CAR-T & Cell Therapy Processing
  • Viral Vector & Gene Therapy Manufacturing
  • Analytics & Quality Control
  • Logistics & Up-scale Processes

For more information on the agenda of the conference, you can write to us at amit.shelke@marketsandmarkets.com




Who Should Attend ?

Industry Professionals

Engineers, scientists, academics and professionals working in 

  • Cell Culture
  • Cell Therapy
  • Upstream Processing
  • Biotechnology
  • Stem Cell therapy
  • Process Development
  • Bioprocessing
  • Downstream Processing
  • Quality Control
  • Bioengineering
  • Scale-up/out
  • Data management for cell-based products
  • Bioprocess development
  • Cellular Therapy
  • Gene Therapy
  • Therapeutics
  • Pharmacology
  • Quality Control
  • Biotherapeutics
  • Cell Engineering
  • Regulatory affairs

Academia: Universities and Research Institute 

Scientists/Professors/Researchers/Project leaders in
  • Cell therapy
  • Gene therapy
  • Cell culture
  • Cell Engineering
  • Bioprocessing
  • Biochemistry
  • Bioengineering
  • Biomaterials
  • Chemical Engineering
  • Molecular Biology
  • Material Sciences
  • Pharmacology
  • Biotechnology

Advisory Panel

  • Manuel Carrondo
    Professor of Chemical and Biochemical Engineering, FCT-UNL, Vice-President
    Institute of Experimental Biology and Technology (iBET), Portugal


  • Stefano Baila
    Industrialization Manager
    Celyad, Brussels, Belgium


  • Tiffany Rau
    Head of Technical Operations (Process Development to Commercialization (Vial thaw to API) and Bioreactor Development)
    Evonik, San Fransisco, USA


  • Benoît Champluvier
    Chief Technology and Manufacturing Officer
    BONE THERAPEUTICS S.A, Brussels, Belgium


  • Peter Hollands
    Group Chief Scientific Officer and Executive Director
    WideCells Group PLC, UK


  • Joanne Mountford

    Honorary Associate Professor, University of Glasgow, Scotland
  • David Brindley

    Senior Research, Fellow In Healthcare Translation, University of Oxford, United Kingdom
  • Bo Kara

    Head Process Development, Cell & Gene Therapy Platform CMC, GSK, United Kingdom
  • Matthew Durdy

    Chief Business officer, CT Catapult, United Kingdom
  • Mannuel Carrando

    Vice President, IBET, Portugal
  • Stefano Baila

    Holding F.I.S, Belgium
  • Angeliki Grammenos

    Manager Regulatory Affairs, Bone Therapeutics, Belgium
  • Shimon Slavin

    Professor of Medicine, Biotherapy International, Israel
  • Robert Thomas

    Professor of Manufacturing for Cell and Gene Therapies, Loughborough University, United Kingdom
  • Vicki Coutinho

    Director, Regulatory Affairs , Autolus Ltd., United Kingdom
  • Sarah Snykers

    QC Manager, Celyad, Belgium
  • Jef Pinxteren

    Director process development, Promethera, Belgium
  • Yuan Zhao

    Leader, Gene Therapy Section, NIBSC, United Kingdom
  • Lior Raviv

    VP Development ,Pluristem Therapeutics, Israel
  • Pierre Heimendinger

    Head of Pharmaceutical Development, TxCell, France
  • Lisa O'Flynn

    Head of Process Development, Orbsen Therapeutics, Ireland



Eppendorf - We Know Bioprocessing

By exploiting the strong synergies in bioreactor technology and polymer manufacturing, Eppendorf has emerged as a global player and valuable resource to its customers. With an integrated portfolio comprising software, instruments, consumables, and services, we can satisfy the demands of bioprocess development through production. In that way and in line with our corporate mission, we contribute to the efforts of Eppendorf customers worldwide to improve human living conditions.

MarketsandMarkets provides a variety of direct and indirect marketing and networking opportunities for sponsors and exhibitors. 


All refreshment breaks and lunches take place in the main exhibition ensuring that exhibitors enjoy maximum time to meet and network with senior level attendees. 

Speaking and Workshop Opportunities

  • 15 minute small company showcase presentations.
  • 30 minute presentations on the main conference programme.
  • 25 minute satellite symposiums.
  • 60 minute presentation/workshop on the main conference programme.

Please enquire for pre and post events workshop options. 

Pre-arranged One-on-One Meetings

Prearranged one-on-one meetings ensure that you have personal time with your choice of delegates. Twenty-minute meetings take place during refreshment breaks. Full delegate profiles are provided prior to the conference to ensure that onsite, you meet with relevant delegates who are truly interested in your products and services. Meetings can take place on your exhibition or in your own private meeting area. 

Pre-event Support

MnM Conferences provide full service pre-event marketing and branding support. Opportunities available include: 

  • Your logo and company description on the event website.
  • Your logo on all marketing materials as a sponsor.
  • Pre-event email shots to attending delegates to increase your onsite exposure.
  • Articles about your products and services in our monthly event newsletter.

For sponsorship opportunities please contact us at events@marketsandmarkets.com

Media partners


To support 3rd Annual Bioprocessing of Advanced Therapies Congress, contact amit.shelke@marketsandmarkets.com


For more information on the venue of the conference, you can write to us at events@marketsandmarkets.com